Market revenue in 2023 | USD 101.4 million |
Market revenue in 2030 | USD 204.0 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Lvads |
Fastest growing segment | LVADs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | LVADs, Heart-lung Machine |
Key market players worldwide | Picard Medical, Carmat, BiVACOR, Abbott Laboratories, Johnson & Johnson, Symbion, LivaNova PLC, Getinge AB ADR, Terumo Corp, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial hearts market will help companies and investors design strategic landscapes.
Lvads was the largest segment with a revenue share of 54.14% in 2023. Horizon Databook has segmented the Japan artificial hearts market based on lvads, heart-lung machine covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan artificial hearts market , including forecasts for subscribers. This country databook contains high-level insights into Japan artificial hearts market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account